Acute rheumatic fever and its consequences: A persistent threat to developing nations in the 21st century

Autoimmunity Reviews

Volumn 9, Issue 2, 2009, Pages 117-123

  Lee, Jennifer L ^a   Naguwa, Stanley M ^a   Cheema, Gurtej S ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Group A streptococcus pharyngitis; Rheumatic fever; Rheumatic heart disease; Sydenham's chorea

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BENZATHINE PENICILLIN; CARBAMAZEPINE; CORTICOSTEROID; DIGOXIN; DIURETIC AGENT; ERYTHROMYCIN; IMMUNOGLOBULIN; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PENICILLIN V; PREDNISONE; SALICYLIC ACID; STREPTOCOCCUS VACCINE; SULFONAMIDE; VALPROIC ACID;

AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; CARDITIS; CHOREA MINOR; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; GROUP A STREPTOCOCCAL INFECTION; HEART BLOCK; HEART FAILURE; HEART INJURY; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MOLECULAR MIMICRY; MONOTHERAPY; MORTALITY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PERICARDITIS; PHARYNGITIS; POLYARTHRITIS; PREVALENCE; PRIMARY PREVENTION; PROGNOSIS; PUBLIC HEALTH PROBLEM; REACTIVE ARTHRITIS; RECOMMENDED DRUG DOSE; RECURRENCE RISK; REVIEW; RHEUMATIC DISEASE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK MANAGEMENT; RISK REDUCTION; SECONDARY PREVENTION; SINGLE DRUG DOSE; SUBCUTANEOUS NODULE; UNSPECIFIED SIDE EFFECT; VACCINATION; VACCINE PRODUCTION; VALVULAR HEART DISEASE; VALVULOPLASTY;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL VACCINES; CATASTROPHIC ILLNESS; CHILD; DEVELOPING COUNTRIES; DIAGNOSIS, DIFFERENTIAL; HISTORY, 21ST CENTURY; HUMANS; MYOCARDITIS; RHEUMATIC HEART DISEASE; STREPTOCOCCUS PYOGENES;

EID: 70449094377     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.04.002     Document Type: Review

References (40)

1. Carapetis J.R., Steer A.C., Mulholland E.K., and Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 5 (2005) 685-694
2. Carapetis J.R., McDonald M., and Wilson N.J. Acute rheumatic fever. Lancet 366 (2005) 155-168
3. Tibazarwa K.B., Volmink J.A., and Mayosi B.M. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 94 (2008) 1534-1540
4. Tani L.Y., Veasy L.G., Minich L.L., and Shaddy R.E. Rheumatic fever in children younger than 5 years: is the presentation different?. Pediatrics 112 (2003) 1065-1068
5. Miyake C.Y., Gauvreau K., Tani L.Y., Sundel R.P., and Newburger J.W. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 120 (2007) 503-508
6. Shulman S.T., Stollerman G., Beall B., Dale J.B., and Tanz R.R. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis 42 (2006) 441-447
7. Guilherme L., Ramasawmy R., and Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol 66 (2007) 199-207
8. Martins T.B., Veasy L.G., and Hill H.R. Antibody responses to group A streptococcal infections in acute rheumatic fever. Pediatr Infect Dis J 25 (2006) 832-837
9. Guilherme L., Kalil J., and Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39 (2006) 31-39
10. Erdem G., Mizumoto C., Esaki D., Reddy V., Kurahara D., Yamaga K., et al. Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin Infect Dis 45 (2007) e20-e24
11. Veasy L.G., Tani L.Y., Daly J.A., Korgenski K., Miner L., Bale J., et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113 (2004) e168-e172
12. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 268 (1992) 2069-2073
13. Herrold K., Herrold E.M., Bograd A.J., Richmond M., Flynn P.A., Cooper R.S., et al. The malignant course of acute rheumatic fever in the modern era: implications for early surgical intervention in cases of bivalvular insufficiency with impaired ventricular function. Pediatr Cardiol 29 (2008) 297-300
14. Tubridy-Clark M., and Carapetis J.R. Subclinical carditis in rheumatic fever: a systematic review. Int J Cardiol 119 (2007) 54-58
15. Ferrieri P. Proceedings of the Jones Criteria workshop. Circulation 106 (2002) 2521-2523
16. Panamonta M., Chaikitpinyo A., Auvichayapat N., Weraarchakul W., Panamonta O., and Pantongwiriyakul A. Evolution of valve damage in Sydenham's chorea during recurrence of rheumatic fever. Int J Cardiol 119 (2007) 73-79
17. Williamson L., Bowness P., Mowat A., and Ostman-Smith I. Lesson of the week: difficulties in diagnosing acute rheumatic fever-arthritis may be short lived and carditis silent. BMJ 320 (2000) 362-365
18. Hilario M.O., and Terreri M.T. Rheumatic fever and post-streptococcal arthritis. Best Pract Res Clin Rheumatol 16 (2002) 481-494
19. Demiroren K., Yavuz H., Cam L., Oran B., Karaaslan S., and Demiroren S. Sydenham's chorea: a clinical follow-up of 65 patients. J Child Neurol 22 (2007) 550-554
20. Alvarenga P.G., Hounie A.G., Mercadante M.T., Diniz J.B., Salem M., Spina G., et al. Obsessive-compulsive symptoms in heart disease patients with and without history of rheumatic fever. J Neuropsychiatry Clin Neurosci 18 (2006) 405-408
21. Thatai D., and Turi Z.G. Current guidelines for the treatment of patients with rheumatic fever. Drugs 57 (1999) 545-555
22. Barash J., Mashiach E., Navon-Elkan P., Berkun Y., Harel L., Tauber T., et al. Differentiation of post-streptococcal reactive arthritis from acute rheumatic fever. J Pediatr 153 (2008) 696-699
23. Lopez-Benitez J.M., Miller L.C., Schaller J.G., Moreno L.M., and de Canata M.E. Erroneous diagnoses in children referred with acute rheumatic fever. Pediatr Infect Dis J 27 (2008) 181-182
24. Harlan G.A., Tani L.Y., and Byington C.L. Rheumatic fever presenting as monoarticular arthritis. Pediatr Infect Dis J 25 (2006) 743-746
25. Eisenstein E.M., and Navon-Elkan P. Acute rheumatic fever associated with Henoch-Schonlein purpura: report of three cases and review of the literature. Acta Paediatr 91 (2002) 1265-1267
26. Cilliers A.M. Rheumatic fever and its management. BMJ 333 (2006) 1153-1156
27. Chopra P., and Gulwani H. Pathology and pathogenesis of rheumatic heart disease. Indian J Pathol Microbiol 50 (2007) 685-697
28. Carapetis J.R., Hardy M., Fakakovikaetau T., Taib R., Wilkinson L., Penny D.J., et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med 5 (2008) 411-417
29. Meira Z.M., Goulart E.M., Colosimo E.A., and Mota C.C. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 91 (2005) 1019-1022
30. Fae K.C., Diefenbach da Silva D., Bilate A.M., Tanaka A.C., Pomerantzeff P.M., Kiss M.H., et al. PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J Autoimmun 31 (2008) 136-141
31. Shoenfeld Y., Selmi C., Zimlichman E., and Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31 (2008) 325-330
32. Cilliers A.M., Manyemba J., and Saloojee H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev (2003) CD003176
33. Saxena A. Treatment of rheumatic carditis. Indian J Pediatr 69 (2002) 513-516
34. Wang Y.C., Tsai F.C., Chu J.J., and Lin P.J. Midterm outcomes of rheumatic mitral repair versus replacement. Int Heart J 49 (2008) 565-576
35. Walker A.R., Tani L.Y., Thompson J.A., Firth S.D., Veasy L.G., and Bale Jr. J.F. Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr 151 (2007) 679-683
36. Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 (2007) 1736-1754
37. Soudarssanane M.B., Karthigeyan M., Mahalakshmy T., Sahai A., Srinivasan S., Subba Rao K.S., et al. Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option. Indian J Pediatr 74 (2007) 567-570
38. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 923 (2004) 1-122 [back cover]
39. Dajani A., Taubert K., Ferrieri P., Peter G., and Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 96 (1995) 758-764
40. Udi N., and Yehuda S. Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7 (2008) 445-452